Standardization of pelvic lymphadenectomy performed at radical cystectomy: Can we establish a minimum number of lymph nodes that should be removed?

Cancer

Volumn 107, Issue 10, 2006, Pages 2368-2374

  Koppie, Theresa M ^a   Vickers, Andrew J ^a   Vora, Kinjal ^a   Dalbagni, Guido ^a   Bochner, Bernard H ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bladder neoplasm; Lymph node dissection; Prognosis; Radical cystectomy

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER SURVIVAL; CYSTECTOMY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; STANDARDIZATION; TRANSITIONAL CELL CARCINOMA;

AGED; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PELVIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 33751004132     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22250     Document Type: Article

References (16)

1. Leissner J, Hohenfellner R, Thuroff JW, et al. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int. 2000;85:817-823.
2. Herr HW, Bochner BH, Dalbagni G, et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol. 2002;167:1295-1298.
3. Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base. J Urol. 2003;169:946-950.
4. Harrell F. Regression Modeling Strategies. New York: Springer; 2001.
5. Konety BR, Joslyn SA. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program. J Urol. 2003;170:1765-1771.
6. Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J Urol. 2003;169:943-945.
7. Fleischmann A, Thalmann GN, Markwalder R, et al. Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor. J Clin Oncol. 2005;23:2358-2365.
8. Abdel-Latif M, Abol-Enein H, El-Baz M, et al. Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol. 2004;172:85-89.
9. Stein JP, Skinner DG. Results with radical cystectomy for treating bladder cancer: a 'reference standard' for highgrade, invasive bladder cancer. BJU Int. 2003;92:12-17.
10. Horzic M, Kopljar M. Minimal number of lymph nodes that need to be examined for adequate staging of colorectal cancer-factors influencing lymph node harvest. Hepatogastroenterology. 2005;52:86-89.
11. Gumus M, Yumuk PF, Atalay G, et al. What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery? Tumori. 2005;91:168-172.
12. Herr H, Lee C, Chang S, et al. Standardization of radical cystectomy and pelvic lymph node dissection for bladder cancer: a collaborative group report. J Urol. 2004;171:1823-1828; discussion 1827-1828.
13. Weingartner K, Ramaswamy A, Bittinger A, et al. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol. 1996;156:1969-1971.
14. Bochner BH, Cho D, Herr HW, et al. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J Urol. 2004;172:1286-1290.
15. Herr HW, Faulkner JR, Grossman HB, et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol. 2004;22:2781-2789.
16. Bochner BH, Herr HW, Reuter VE. Impact of separate versus en bloc pelvic lymph node dissection on the number of lymph nodes retrieved in cystectomy specimens. J Urol. 2001;166:2295-2296.